Skip to content

    ADD & ADHD Health Center

    Font Size

    FDA OKs ADHD Drug Vyvanse for Adults

    Vyvanse Already on the Market for Kids With Attention Deficit Hyperactivity Disorder
    WebMD Health News
    Reviewed by Louise Chang, MD

    April 23, 2008 -- The FDA has approved the drug Vyvanse for the treatment of attention deficit hyperactivity disorder (ADHD) in adults, according to the drug company Shire, which makes Vyvanse.

    Vyvanse, a stimulant drug, was first approved by the FDA in 2007 to treat ADHD symptoms in children ages 6-12.

    Shire says the FDA approved Vyvanse for adult use based on a clinical trial of 414 adults ages 18-55 who took Vyvanse or a placebo pill for four weeks. Patients taking Vyvanse "experienced significant improvements in ADHD symptom control within one week of treatment with once-daily Vyvanse," says Shire.

    All three doses of Vyvanse that were studied -- 30 milligrams, 50 milligrams, and 70 milligrams -- trumped the placebo; the most commonly reported adverse events were decreased appetite, difficulty in falling asleep, and dry mouth, notes Shire.

    Today on WebMD

    Post it notes
    Symptoms and treatments.
    Close up of eye
    What's zapping your focus?
    man driving car
    How to manage your impulses.
    contemplating woman
    Learn to stop procrastinating.
    concentration killers
    Woman taking a vitamin or supplement
    ADHD and Substance Abuse
    Reduce Side Effects ADHD Medications

    woman with adhd doing college homework
    smiling man
    ADHD in Marriage and Romantic Relationships
    Adult man lying awake in bed